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Abstracts / Urological Science 27 (2016) S36eS52 S47Purpose: The study aimed to evaluate the possibility of applying 18F-
ﬂuorodeoxyglucose positron-emission tomography (FDG PET/CT) for
detecting upper tract cancer.
Materials and Methods: 37 patients who had undergone preoperative.
FDG PET/CT for their suspected upper tract urothelial cancer from January
2010 to December 2015, were retrospectively enrolled for comparisonwith
the postoperative histological ﬁndings of nephroureterectomy.
Results: The histological ﬁndings revealed 39 urothelial malignancies in
37 nephroureterectomy specimens. The sensitivity of FDG PET CT was
87.1% (34/39) in detecting the primary upper tract urothelial cancer. 2
patients without FDG PET/CT avid tumor were diagnosed with Ta, low
grade urothelial cancer. In two patients with two separated upper tract
tumors by histology of nephroureterectomy, only one avid tumor was
found in FDG PET/CT. In one patient with annular type T3 ureteral cancer,
no deﬁnite evidence of FDG-avid tumor was found in the ureter.
Conclusion: FDG PET/CT may serve as a feasible supplementary method
for the diagnosis of upper tract urothelial malignancies but may miss low
grade, low stage, small size or annular type of urothelial cancer.
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Purpose: Renal AML is considered as a benign kidney tumor with hamar-
tomatous features.However, itoften leads tohemorrhagic complications such
asretroperitonealhematomaorhematuria if large size. Invasive interventions
includingembolization, nephron-sparing surgery, or evennephrectomywere
suggested for larger tumor. Robotic-assisted laparoscopic partial nephrec-
tomyhelps in reducing surgical time,warm ischemia time, surgical technique
difﬁculty, intraoperative blood loss comparing to traditional laparoscopic
partial nephrectomy. Retroperitoneal approach provides better identiﬁcation
to renal pedicle control; prevent bowel injury and sooner bowel recovery.
However, there was less literature in reporting the robotic-assisted laparo-
scopic partial nephrectomy via retroperitoneal approach for angiomyoli-
poma. Hence, we are here to share our hospital’s clinical experience.
Materials andMethods: In Chi-MeiMedical Center, we performed robotic-
assisted retroperitoneoscopic partial nephrectomysinceAugust 2012, there
were 15 patients met the surgical indication of angiomyolipoma (tumor >
4cm or symptomatic) and underwent the nephron-sparing surgery with
single surgeon, as the inclusion criteria. The tumor’s characteristic, intra-
operative statuses, post-operative follows up outcome were analysis.
Results: From august 2012 to September 2015, there were 3 male and 12
female patients met the inclusion criteria. The mean age was 53-year-old.
Most of themwere asymptomatic (86%) but larger tumor, the average tumor
sizewas 5.22cm (2.3-13). The average nephrometry scorewas 6.35; Console
time was 121mins (40e238); warm ischemia time was 15 min (5e28);
estimated blood loss was 550ml (100e1300). Only 2 (13%) of patients need
intraoperative transfusion; 2 (13%) patients need post-operative emboliza-
tion (grade 3a complication). The average post-operative estimated
glomerular ﬁltration rate loss was 24% (7e40). The mean length of hospital
staywas 4 days (2e8). Therewas no readmission ratewithin 30 days. Only 1
patient (6%) showed residual tumor during follow up imaging study
Conclusion: Robotic-assisted retroperitoneoscopic partial nephrectomy
has acceptable morbidity and outcomes, it is safe and feasible in patient of
benign renal angiomyolipoma.
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Purpose: To report our experience with radical cystectomy by open or
laparoscopy method as applied to an older patient population with regard
to perioperative measures and pathologic outcomes.
Materials and Methods: A total of 48 patients underwent cystectomy and
extracorporeal urinary diversion at our institution from September 2008
through March 2016 for clinically localized bladder cancer. The clinical
characteristics, operative outcomes, and pathologic results of the consec-
utive cases were categorized by age (younger, age <65 years vs older, age
S65 years).
Results: The outcomes of the 21 younger and 27 older patients, including
10 patientsS 80 years old, were assessed. The number of patients received
cystectomy by open vs. laparoscopy method in the younger and older
groups were 7 vs. 14 and 12 vs.11, respectively. The numbers of different
urine diversions methods (young vs .old) were1vs. 5 (ureter-
ocutaneostomy), 10 vs. 10 (ileal conduit), 4 vs.6 (neobladder). No differ-
ences were observed between the 2groups in American Society of
Anesthesiologists score, operation time, blood loss, time to discharge,
complication rate, open conversion rate, 30-D and 90-D mortality rate.
Also, no signiﬁcant differences were found in the surgical pathologic
ﬁndings, including the organ-conﬁned rate and lymph node yield.
Conclusion: Older patients do not appear to have any signiﬁcant differ-
ences or compromises with regard to the perioperative and pathologic
outcomes after radical cystectomy by either open or laparoscopy method
and urine diversionwith or without neobladder. Thus age alone should not
preclude radical cystectomy or for certain type of urine diversion.
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Purpose: Adjuvant therapy for post-operative locally advanced upper tract
urothelial carcinoma (UTUC) is still controversial. We are wondering if
there is any prognostic factors on the recurrence of T3 UTUC for clinical
decision on post-operative adjuvant therapy.
Materials and Methods: Medical records of 192 pT3 UTUC patients from
2005e2013 were reviewed. Collected variables as age, follow up time,
gender, tumor location, nodal status, smoking, grade, lymphovascular in-
vasion (LVI), ESRD, tumor subtype and recurrence. Multivariate analysis of
the prognostic factors on the tumor recurrence.
Results: 192 patients with median follow up duration 35.6 months were
analyzed. 95 patients (49%) with systemic recurrence were noted in the
follow up duration. Multivariate analysis of the risk factors for the recur-
rence showed signiﬁcance on nodal status, smoking and lymphovascular
invasion (LVI). We classiﬁed the patients into 3 groups as 1. lymph nodes
negative 2. lymph nodes negative with LVI or smoking 3.lymph nodes
positive. The Kaplan-Meier recurrence free survival curve showed signif-
icant difference on the 3 groups.
Conclusion: For patients with clinical PT3 UTUC, lymph nodes metastasis,
lympho-vascular invasion and smoking status were independent poor
prognostic factors. These results may be used to counsel patients towards
post-operative adjuvant therapy.
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Purpose: Nephron-sparing surgery for renal tumor was the standard
procedure for the resectable renal tumor in order to preserve renal func-
tion. It was evolved from open surgery to the minimal invasive surgery
